Four Months And Ticking: No New Opinions From EU Medtech Expert Panels
The EU expert panels set up to support the review of high-risk products had produced three opinions on medical devices and 15 “views” on IVDs by the start of March. Nothing has been published since.
You may also be interested in...
The European Commission has launched an initiative to ensure products without a medical purpose that fall under the Medical Device Regulation are appropriately classified by risk, and subject to the same pre- and post-market requirements as comparable medical devices.
The EU must keep its medtech regulation under review as rapidly changing technology and external market factors may be challenging the operability of some aspects of the new medtech regulations, especially for less mature businesses and SMEs. Legal medtech expert, Shuna Mason, of CMS explains why.
Latest information from the European Commission suggest that future notified bodies designated under the MDR, and even the IVDR, may not be in a position to issue certificates until March 2023.